Projects

Mgr. Svetlana Miklíková, PhD.

International

Finished
  • Resistance under treatment in breast cancer
    Program: ERANET
    Duration: 1. 8. 2020 – 31. 5. 2024
  • Innovative Nanopharmaceuticals: Targeting Breast Cancer Stem Cells by a Novel Combination of Epigenetic and Anticancer Drugs with Gene Therapy
    Program: ERANET
    Duration: 1. 1. 2017 – 30. 6. 2021

National

Finished
  • Unraveling the role of genetic predispositions in the context of breast cancer tumor microenvironment
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Markers overlapping chemoresistance and metastatic potential in colorectal cancer - aldehyde dehydrogenase and its clinical relevance
    Program: Other projects
    Duration: 1. 11. 2019 – 31. 12. 2022
  • Mechanism of the mesenchymal stromal cell-induced tolerance to antitumor treatment and targeted therapeutic intervention in the breast cancer cells
    Program: SRDA
    Duration: 1. 7. 2017 – 31. 12. 2021
  • Identification and validation of signalling pathways associated with circulating tumor cells in breast cancer
    Program: SRDA
    Duration: 1. 7. 2017 – 30. 6. 2021
  • Comparison of functional characteristics of adipose tissue-derived mesenchymal stromal cells isolated isolated from healthy donors and oncological patients
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • Role of Stress Response Induced in Mesenchymal Stromal Cells in Extrinsic Drug Resistance of Human Tumor Cells
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Mechanisms of interactions and bystander effect mediated by mesenchymal stromal cells expressing prodrug-converting genes on tumour stem cells
    Program: SRDA
    Duration: 1. 10. 2013 – 30. 9. 2017
  • Cytotoxic Effect of Engineered Mesenchymal Stromal Cells on Human Chemoresistant Tumour Cells and Cancer Stem Cells
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2016
  • -
    Program: Other projects
    Duration: 1. 1. 2016 – 31. 12. 2016
  • Targeted Augmented Cellular Therapy against Tumor Initiating and Chemoresistant Cells
    Program: SRDA
    Duration: 1. 7. 2012 – 31. 12. 2015
  • Molecular mechanisms of tumor-driven mesenchymal stromal cells‘ differentiation
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2014
Employees